Results 171 to 180 of about 1,342,432 (229)

Letter: Low-FODMAP Diet in Irritable Bowel Syndrome-Beyond the Hype! Authors' Reply. [PDF]

open access: yesAliment Pharmacol Ther
Garcia-Cedillo MF   +3 more
europepmc   +1 more source

Beliefs and Experiences of People in Australia Living With Chronic Pelvic Pain, and Associations Between Their Illness Perceptions and Pain

open access: yesAustralian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 5, October 2026.
ABSTRACT Background There are gaps in understanding females' beliefs related to chronic pelvic pain. Beliefs might be linked to illness perceptions and behaviours. Aims (1) Explore beliefs and experiences of Australian females living with chronic pelvic pain, against categories based on clinical guidelines.
Emma Wise   +5 more
wiley   +1 more source

Phenotyping Increased Urge to Defecate in Irritable Bowel Syndrome: Analysis of Symptom, Sensory, and Psychological Profiles. [PDF]

open access: yesUnited European Gastroenterol J
Groen SR   +7 more
europepmc   +1 more source

Review Article: Accelerating Coeliac Disease Clinical Trials—Beyond Celiac Meeting With Industry, Academics, Patients and the FDA

open access: yesAlimentary Pharmacology &Therapeutics, Volume 64, Issue 7, Page 890-896, October 2026.
A 2024 multi‐stakeholder meeting examined how to accelerate coeliac disease drug trials, highlighting key considerations in endpoint selection, symptom–histology alignment and feasibility. Progress requires patient‐centred trials showing symptomatic and intestinal improvement, appropriate gluten challenge, and early regulatory engagement, including ...
Lisa M. Fahey   +11 more
wiley   +1 more source

Tenapanor Beyond Phosphate: Gut Sodium Transport, Stool Transit Time, and Volume Balance in Dialysis Patients

open access: yesHemodialysis International, Volume 30, Issue 4, Page 689-697, October 2026.
ABSTRACT Introduction Tenapanor, a minimally absorbed intestinal NHE3 inhibitor approved for hyperphosphatemia in dialysis, lowers phosphate and reduces intestinal sodium absorption. Its sodium–water signal may have implications beyond phosphate but remains poorly separated from diarrhea‐mediated losses and dialysis prescription artifacts. Methods This
Lucas Maciel de Almeida Corrêa   +8 more
wiley   +1 more source

The Gut Microbiome as a Therapeutic Target in Alopecia Areata: Not Yet Part of the Patient Treatment Plan

open access: yesInternational Journal of Dermatology, Volume 65, Issue 10, Page 2001-2004, October 2026.
ABSTRACT Interest in the gut microbiome as a therapeutic target for treating alopecia areata (AA) has grown considerably. However, existing evidence remains limited and inconsistent. Currently, there is insufficient evidence to recommend microbiome‐directed testing and therapies to patients with AA.
Eric McMullen   +9 more
wiley   +1 more source

An Evaluation of a Dietitian‐Led Webinar for Adults With Coeliac Disease: A Positive Change in Gluten‐Free Food Knowledge and Behaviours

open access: yesJournal of Human Nutrition and Dietetics, Volume 39, Issue 5, October 2026.
ABSTRACT Introduction The only treatment for coeliac disease is the exclusion of all gluten from the diet. Adherence to a gluten free (GF) diet requires knowledge acquisition and changes in behaviours. The service evaluation aimed to evaluate the impact of a dietitian‐led webinar for adults with coeliac disease.
Leah Seamark   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy